---
{"dg-publish":true,"permalink":"/USMLE/Infective disease/Human papillomavirus infection/","tags":["t1"]}
---

# Types
---
- Low-risk HPV types 6 and 11
	- Anogenital warts (condylomata acuminata)
	- <span style="background:rgba(240, 200, 0, 0.2)">Primarily transmitted through sexual contact</span>
- <span style="background:rgba(240, 200, 0, 0.2)">High-risk HPV</span> types 16, 18, 31, and 33
	- [[USMLE/Reproductive/Cervical cancer\|Cervical cancer]] (responsible for 70% of cases) 
	- High risk of [[USMLE/GI/Anal cancer\|anogenital]], oral, and oropharyngeal squamous cell carcinoma
	- <span style="background:rgba(240, 200, 0, 0.2)">Primarily transmitted through sexual contact</span>
- HPV types 1, 2, and 4: cause skin warts, such as <span style="background:rgba(240, 200, 0, 0.2)">common warts (verruca vulgaris) and plantar warts (myrmecias)</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Primarily transmitted through non-sexual skin-to-skin contact or contact with contaminated surfaces</span>
# Etiology
---
## Risk factors
- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Immunology/Congenital immunodeficiency disorders\|Immunodeficiency]] (e.g., due to [[USMLE/Infective disease/Human immunodeficiency virus\|HIV infection]], chemotherapy)</span>
- Additional risk factors for genital/mucosal HPV infections include:
	- Unprotected sex
	- Higher number of lifetime sexual partners
	- Early age at first sexual activity
	- Lack of circumcision in male individuals
# Pathophysiology
---
- HPV expresses the following oncoproteins
	- <span style="background:rgba(240, 200, 0, 0.2)">E6 → inhibition of p53 protein → inhibition of the intrinsic apoptotic pathway and inhibition of p21 protein</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">E7</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Inhibition of [[USMLE/Neurology/Retinoblastoma\|retinoblastoma]] protein (pRb) → increased activity of E2F-family of transcription factors</span>
		- Inhibits p21 and p27 (CDK inhibitors) → increased activity of cyclin-dependent kinase

>[!Mnemonic] 
>6 comes before 7 and P comes before R: E6 inhibits P53 and E7 inhibits pRb

# Pathology
---
- <span style="background:rgba(240, 200, 0, 0.2)">HPV infect [[USMLE/MSK/Skin layers\|stratum basale]], where epithelial cells are replicating</span>
- Epidermal [[USMLE/Pathology/Cellular adaptations\|hyperplasia]] and <span style="background:rgba(240, 200, 0, 0.2)">hyperkeratosis</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Koilocytes</span> 
	- Pathognomonic of an infection with HPV
	- Dysplastic squamous cells characterized by well-defined, clear, balloon-like, <span style="background:rgba(240, 200, 0, 0.2)">perinuclear halo</span> and hyperchromasia![L84976.png](/img/user/appendix/L84976.png)![Pasted image 20250402111905.png](/img/user/appendix/Pasted%20image%2020250402111905.png)
# Nonanogenital manifestations
---
## Common warts (verruca vulgaris)
- Pathogen: particularly low-risk HPV types 2 and 4
- Clinical features
	- Lesions are plaques or papules 
		- <span style="background:rgba(240, 200, 0, 0.2)">Skin-colored or whitish</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Usually firm, often with a rough and scaly surface</span>![L64111.png](/img/user/appendix/L64111.png)![Pasted image 20250114101624.png](/img/user/appendix/Pasted%20image%2020250114101624.png)![Pasted image 20250114101939.png](/img/user/appendix/Pasted%20image%2020250114101939.png)
		- Sometimes have a cauliflower-like appearance
# Anogenital warts (Condylomata acuminata)
- Pathogen: HPV types that infect the mucosal epithelium (e.g., HPV types 6 and 11)
- Clinical features
	- <span style="background:rgba(240, 200, 0, 0.2)">Flat, papular, or pedunculated exophytic, cauliflower-like lesions</span> ![Pasted image 20241020094929.png](/img/user/appendix/Pasted%20image%2020241020094929.png)
	- <span style="background:rgba(240, 200, 0, 0.2)">Located on any part of the anogenital mucosa (e.g., glans penis, vagina, cervix, anal canal) and/or perineal skin</span>
	- Typically asymptomatic; occasionally cause pruritus or pain
- <span style="background:rgba(240, 200, 0, 0.2)">If transmit to children during birth: [[USMLE/Infective disease/Recurrent respiratory papillomatosis\|Laryngeal papillomatosis]]</span>
# Treatment
---
- <span style="background:rgba(240, 200, 0, 0.2)">Imiquimod</span>
	- Local treatment
	- <span style="background:rgba(240, 200, 0, 0.2)">Mechanism of action: toll-like receptor 7 agonist → activates immune cells (i.e., macrophages, monocytes, dendritic cells)</span>![L59895.jpg](/img/user/appendix/L59895.jpg)
	- Indication: actinic keratoses, superficial basal cell carcinomas, herpes simplex infections, and anogenital warts
	- Adverse effects: burning pain at application site, dermal rash, pruritus
